Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs

被引:181
作者
Ashida, S
Nakagawa, H
Katagiri, T
Furihata, M
Iiizumi, M
Anazawa, Y
Tsunoda, T
Takata, R
Kasahara, K
Miki, T
Fujioka, T
Shuin, T
Nakamura, Y
机构
[1] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome,Minato Ku, Tokyo 1088639, Japan
[2] Kochi Med Sch, Dept Urol, Nankoku, Kochi, Japan
[3] Kochi Med Sch, Dept Tumor Pathol, Nankoku, Kochi, Japan
[4] RIKEN, Lab Med Informat, SNP Res Ctr, Yokohama, Kanagawa, Japan
[5] Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan
[6] Iwate Med Univ, Dept Urol, Morioka, Iwate 020, Japan
关键词
D O I
10.1158/0008-5472.CAN-04-0020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To characterize the molecular feature in prostate carcitiogenesis and the putative transition from prostatic intraepithelial neoplasia (PIN) to invasive prostate cancer (PC), we analyzed gene-expression profiles of 20 PCs and 10 high-grade PINs with a cDNA microarray representing 23,040 genes. Considering the histological heterogeneity of PCs and the minimal nature of PIN lesions, we applied laser microbeam microdissection to purify populations of PC and PIN cells, and then compared their expression profiles with those of corresponding normal prostatic epithelium also purified by laser microbeam microdissection. A hierarchical clustering analysis separated the PC group from the PIN group, except for three tumors that were morphologically defined as one very-high-grade PIN and two low-grade PCs, suggesting that PINs and PCs share some molecular features and supporting the hypothesis of PIN-to-PC transition. On the basis of this hypothesis, we identified 21 up-regulated genes and 63 down-regulated genes commonly in PINs and PCs compared with normal epithelium, which were considered to be involved in the presumably early stage of prostatic carcinogenesis. They included AMACR, OR51E2, RODH, and SMS. Furthermore, we identified 41 up-regulated genes and 98 down-regulated genes in the transition from PINs to PCs; those altered genes, such as POV1, CDKN2C, EPHA4, APOD, FASN, ITGB2, LAMB2, PLAU, and TIMP1, included elements that are likely to be involved in cell adhesion or the motility of invasive PC cells. The down-regulation of EPHA4 by small interfering RNA in PC cells lead to attenuation of PC cell viability. These data provide clues to the molecular mechanisms underlying prostatic carcinogenesis, and suggest candidate genes the products of which might serve as molecular targets for the prevention and treatment of PC.
引用
收藏
页码:5963 / 5972
页数:10
相关论文
共 29 条
  • [1] Molecular genetics of prostate cancer
    Abate-Shen, C
    Shen, MM
    [J]. GENES & DEVELOPMENT, 2000, 14 (19) : 2410 - 2434
  • [2] Down-regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer
    Chen, LM
    Hodge, GB
    Guarda, LA
    Welch, JL
    Greenberg, NM
    Chai, KX
    [J]. PROSTATE, 2001, 48 (02) : 93 - 103
  • [3] Pathological and molecular aspects of prostate cancer
    DeMarzo, AM
    Nelson, WG
    Isaacs, WB
    Epstein, JI
    [J]. LANCET, 2003, 361 (9361) : 955 - 964
  • [4] Delineation of prognostic biomarkers in prostate cancer
    Dhanasekaran, SM
    Barrette, TR
    Ghosh, D
    Shah, R
    Varambally, S
    Kurachi, K
    Pienta, KJ
    Rubin, MA
    Chinnaiyan, AM
    [J]. NATURE, 2001, 412 (6849) : 822 - 826
  • [5] Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse
    Di Cristofano, A
    De Acetis, M
    Koff, A
    Cordon-Cardo, C
    Pandolfi, PP
    [J]. NATURE GENETICS, 2001, 27 (02) : 222 - 224
  • [6] Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas
    Doll, JA
    Stellmach, VM
    Bouck, NP
    Bergh, ARJ
    Lee, C
    Abramson, LP
    Cornwell, ML
    Pins, MR
    Borensztajn, J
    Crawford, SE
    [J]. NATURE MEDICINE, 2003, 9 (06) : 774 - 780
  • [7] EMMERTBUCK MR, 1995, CANCER RES, V55, P2959
  • [8] Prostate cancer epidemiology
    Grönberg, H
    [J]. LANCET, 2003, 361 (9360) : 859 - 864
  • [9] Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer
    Han, M
    Partin, AW
    Piantadosi, S
    Epstein, JI
    Walsh, PC
    [J]. JOURNAL OF UROLOGY, 2001, 166 (02) : 416 - 419
  • [10] KOVI J, 1985, CANCER, V56, P1566, DOI 10.1002/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO